Dr Burzynski and Antineoplastons
Back in the early 1970s, Dr Burzynski discovered that there was a fundamental difference between the peptides in the blood and urine samples of cancer patients versus healthy individuals. The cancer patients were missing some substances that are normally present. He named these antineoplastons. He theorised that by synthesising the missing peptides and putting them … Read more